Antifungal Drug Therapeutic Monitoring: What are the Issues?

[Therapeutic drug monitoring of antifungal agents].

Economic Issues in Therapeutic Drug Monitoring.

The fact that resources for health care are limited has been found as a rationale for the development of pharmacoeconomics. Pharmacoeconomic analysis identifies, measures and compares the costs and the economic, clinical and humanistic outcomes of diseases, drug therapies and programmes directed to these diseases. As health care expenditures have escalated over the past decades, the number of i...

Antifungal therapeutic drug monitoring: established and emerging indications.

Andres Pascual Dept of Medicine, Centre Hospitalier Universitaire Vaudois and University of Lausanne, CH-1011 Lausanne, Switzerland [email protected] 41 21 314 0909 AC CE PT ED Copyright © 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved. Antimicrob. Agents Chemother. doi:10.1128/AAC.00705-08 AAC Accepts, published online ahead of print on...

Antifungal therapeutic drug monitoring: when, how, and why.

In recent years, the incidence of invasive fungal infections (IFI) has risen in parallel with a growing population of patients immunosuppressed as a consequence of different conditions, such as HIV infection, increasingly aggressive surgical techniques, solid organ and hematopoietic transplantations, illness severity of critically ill patients and, in a lower rate, anti-TNF therapies.1–3 In spi...

therapeutic drug monitoring

0